Literature DB >> 22368317

A novel, implicit treatment for language comprehension processes in right hemisphere brain damage: Phase I data.

Connie A Tompkins1, Margaret T Blake, Julie Wambaugh, Kimberly Meigh.   

Abstract

BACKGROUND: This manuscript reports the initial phase of testing for a novel, "Contextual constraint" treatment, designed to stimulate inefficient language comprehension processes in adults with right hemisphere brain damage (RHD). Two versions of treatment were developed to target two normal comprehension processes that have broad relevance for discourse comprehension and that are often disrupted by RHD: coarse semantic coding and suppression. The development of the treatment was informed by two well-documented strengths of the RHD population. The first is consistently better performance on assessments that are implicit, or nearly so, than on explicit, metalinguistic measures of language and cognitive processing. The second is improved performance when given linguistic context that moderately-to-strongly biases an intended meaning. Treatment consisted of providing brief context sentences to prestimulate, or constrain, intended interpretations. Participants made no explicit associations or judgments about the constraint sentences; rather, these contexts served only as implicit primes. AIMS: This Phase I treatment study aimed to determine the effects of a novel, implicit, Contextual Constraint treatment in adults with RHD whose coarse coding or suppression processes were inefficient. Treatment was hypothesized to speed coarse coding or suppression function in these individuals. METHODS #ENTITYSTARTX00026; PROCEDURES: Three adults with RHD participated in this study, one (P1) with a coarse coding deficit and two (P2, P3) with suppression deficits. Probe tasks were adapted from prior studies of coarse coding and suppression in RHD. The dependent measure was the percentage of responses that met predetermined response time criteria. When pre-treatment baseline performance was stable, treatment was initiated. There were two levels of contextual constraint, Strong and Moderate, and treatment for each item began with the provision of the Strong constraint context. OUTCOMES #ENTITYSTARTX00026;
RESULTS: Treatment-contingent gains were evident after brief periods of treatment, for P1 on two treatment lists, and for P2. P3 made slower but still substantial gains. Maintenance of gains was evident for P1, the only participant for whom it was measured.
CONCLUSIONS: This Phase I treatment study documents the potential for considerable gains from an implicit, Contextual constraint treatment. If replicated, this approach to treatment may hold promise for individuals who do poorly with effortful, metalinguistic treatment tasks, or for whom it is desirable to minimize errors during treatment. The real test of this treatment's benefit will come from later phase studies of study, which will test broad-based generalization to various aspects of discourse comprehension.

Entities:  

Year:  2011        PMID: 22368317      PMCID: PMC3285376          DOI: 10.1080/02687038.2010.539784

Source DB:  PubMed          Journal:  Aphasiology        ISSN: 0268-7038            Impact factor:   2.773


  8 in total

1.  Visual aids and structured criteria for improving visual inspection and interpretation of single-case designs.

Authors:  Wayne W Fisher; Michael E Kelley; Joanna E Lomas
Journal:  J Appl Behav Anal       Date:  2003

2.  Mechanisms of discourse comprehension impairment after right hemisphere brain damage: suppression in inferential ambiguity resolution.

Authors:  C A Tompkins; M T Lehman-Blake; A Baumgaertner; W Fassbinder
Journal:  J Speech Lang Hear Res       Date:  2001-04       Impact factor: 2.297

3.  The mechanism of suppression: a component of general comprehension skill.

Authors:  M A Gernsbacher; M E Faust
Journal:  J Exp Psychol Learn Mem Cogn       Date:  1991-03       Impact factor: 3.051

4.  Theoretical Considerations for Understanding "Understanding" by Adults With Right Hemisphere Brain Damage.

Authors:  Connie A Tompkins
Journal:  Perspect Neurophysiol Neurogenic Speech Lang Disord       Date:  2008-06-01

5.  The role of knowledge in discourse comprehension: a construction-integration model.

Authors:  W Kintsch
Journal:  Psychol Rev       Date:  1988-04       Impact factor: 8.934

6.  Mechanisms of discourse comprehension impairment after right hemisphere brain damage: suppression in lexical ambiguity resolution.

Authors:  C A Tompkins; A Baumgaertner; M T Lehman; W Fassbinder
Journal:  J Speech Lang Hear Res       Date:  2000-02       Impact factor: 2.297

7.  Activation and maintenance of peripheral semantic features of unambiguous words after right hemisphere brain damage in adults.

Authors:  Connie A Tompkins; Wiltrud Fassbinder; Victoria L Scharp; Kimberly M Meigh
Journal:  Aphasiology       Date:  2008-02-01       Impact factor: 2.773

8.  Coarse coding and discourse comprehension in adults with right hemisphere brain damage.

Authors:  Connie A Tompkins; Victoria L Scharp; Kimberly M Meigh; Wiltrud Fassbinder
Journal:  Aphasiology       Date:  2008-02-01       Impact factor: 2.773

  8 in total
  3 in total

1.  Contextual Constraint Treatment for coarse coding deficit in adults with right hemisphere brain damage: generalisation to narrative discourse comprehension.

Authors:  Margaret Lehman Blake; Connie A Tompkins; Victoria L Scharp; Kimberly M Meigh; Julie Wambaugh
Journal:  Neuropsychol Rehabil       Date:  2014-07-01       Impact factor: 2.868

2.  Generalization of a Novel, Implicit Treatment for Coarse Coding Deficit in Right Hemisphere Brain Damage: A Single Subject Experiment.

Authors:  Connie A Tompkins; Victoria L Scharp; Kimberly Meigh; Margaret Lehman Blake; Julie Wambaugh
Journal:  Aphasiology       Date:  2012-05-01       Impact factor: 2.773

3.  The role of the right hemisphere in semantic control: A case-series comparison of right and left hemisphere stroke.

Authors:  Hannah E Thompson; Lauren Henshall; Elizabeth Jefferies
Journal:  Neuropsychologia       Date:  2016-03-02       Impact factor: 3.139

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.